SCHEMBL836617

SCHEMBL836617

CC(C)(C)c1cc(C(C)(c2ccccc2)c2ccc(O)c(C(C)(C)C)c2)ccc1O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 4/20 0.68
ESR2 Q92731 3/20 0.68
ALDH1A1 P00352 7/20 0.52
ALOX15 P16050 3/20 0.52
HSD17B10 Q99714 2/20 0.52
CYP2C9 P11712 2/20 0.52
NR1I2 O75469 1/20 0.52
LMNA P02545 1/20 0.52
MIF P14174 1/20 0.52
TYR P14679 1/20 0.52
HTT P42858 1/20 0.52
NFE2L2 Q16236 1/20 0.52
TDP1 Q9NUW8 2/20 0.50
TSHR P16473 2/20 0.50
MAPT P10636 3/20 0.45
CYP1A2 P05177 2/20 0.45
KDM4E B2RXH2 1/20 0.45
ATP2A2 P16615 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
ATP2A3 Q93084 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29948246 1.00 ESR1 (0.68) ESR1ESR2ALDH1A1ALOX15HSD17B10
SCHEMBL7917289 0.87 ALDH1A1 (0.53) ESR1ESR2ALDH1A1ALOX15HSD17B10
SCHEMBL7523323 0.85 ESR1 (0.58) ESR1ESR2ALDH1A1ALOX15HSD17B10
SCHEMBL7705085 0.85 ESR1 (0.57) ESR1ESR2ALDH1A1ALOX15HSD17B10
SCHEMBL6888712 0.84 ESR1 (0.57) ESR1ESR2ALDH1A1ALOX15HSD17B10
Benzene SCHEMBL28155736 0.84 ALDH1A1 (0.61) ESR1ESR2ALDH1A1ALOX15HSD17B10
SCHEMBL2442828 0.83 ESR1 (0.65) ESR1ESR2ALDH1A1ALOX15HSD17B10
SCHEMBL23861356 0.82 ESR1 (0.75) ESR1ESR2ALDH1A1ALOX15HSD17B10
SCHEMBL18399452 0.82 ESR1 (0.58) ESR1ESR2ALDH1A1ALOX15HSD17B10
SCHEMBL18400645 0.82 ESR1 (0.58) ESR1ESR2ALDH1A1ALOX15HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 207 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-1075522-A None JP disclosed
JP-1062353-A None JP disclosed
JP-1066235-A None JP disclosed
JP-1075523-A None JP disclosed
JP-1045424-A None JP disclosed
JP-1062352-A None JP disclosed
JP-1087622-A None JP disclosed
JP-1087621-A None JP disclosed
JP-1178519-A None JP disclosed
US-12600856-B2 Resin composition, formed article, and, formed article with hard coat layer MITSUBISHI CHEMICAL CORPORATION (JP) 2026-04-14 US disclosed
JP-H01178519-A RESIN FOR OPTICAL MATERIAL DAICEL CHEM IND LTD 1989-07-14 JP disclosed
JP-S6487622-A POLYCARBONATE COPOLYMER DAICEL CHEM 1989-03-31 JP disclosed
JP-S6487621-A POLYCARBONATE COPOLYMER DAICEL CHEM 1989-03-31 JP disclosed
JP-S6475522-A POLYCARBONATE COPOLYMER DAICEL CHEM 1989-03-22 JP disclosed
JP-S6475523-A POLYCARBONATE COPOLYMER DAICEL CHEM 1989-03-22 JP disclosed
JP-S6466235-A AROMATIC POLYCARBONATE TERPOLYMER DAICEL CHEM 1989-03-13 JP disclosed
JP-S6462353-A POLYMER COMPOSITION HAVING EXCELLENT COMPATIBILITY DAICEL CHEM 1989-03-08 JP disclosed
JP-S6462352-A POLYMER COMPOSITION HAVING EXCELLENT COMPATIBILITY DAICEL CHEM 1989-03-08 JP disclosed
JP-S6445424-A POLYCARBONATE POLYMER DAICEL CHEM 1989-02-17 JP disclosed
US-4045499-A ACID CATALYSTS BAYER AKTIENGESELLSCHAFT (DT) 1977-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12600856-B2 Resin composition, formed article, and, formed article with hard coat layer ARID2, ASH2L, COL2A1 ESR1 3195/4885ESR2 1945/4885ALDH1A1 1609/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.